4th Quarter - Termination
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) for NOVARTIS
Client
Income
$50,000
Expenses
—
Terminated
Dec 31, 2014
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
The Federal, Food, Drug and Cosmetic Act The Prescription Drug User Fee Act (PDUFA) Patient Protection and Affordable Care Act Biologics Price Competition and Innovation Act Protecting Consumer Access to Generic Drugs Act The Food and Drug Administration Safety and Innovation Act (FDASIA) Drug Quality and Security Act Preserving Access to Orphan Drugs Act S#1128 HR#2315
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY | — |
| ARI MITTLEMAN | — |
| VINCENT A. ROBERTI, SR. | — |
| RICHARD CHARLES WHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.